Ignite Creation Date:
2025-12-25 @ 2:56 AM
Ignite Modification Date:
2026-03-02 @ 9:03 AM
Study NCT ID:
NCT04124133
Status:
COMPLETED
Last Update Posted:
2019-10-11
First Post:
2019-10-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of Efficacy and Safety of Ialuset Cream and Gauze in Second-degree Burns on Child
Sponsor:
Laboratoires Genévrier
Organization:
Study Overview
Official Title:
Observational Retrospective Study Evaluating Efficacy and Safety of Ialuset Cream or Gauzepad in Second Degree Burns Use for Children
Status:
COMPLETED
Status Verified Date:
2019-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Observational retrospective monocentric study occured in the univeristy hospital center of Bensançon the department of pediatric surgery.
Data of patients treated in the hospital between January 2016 and January 2019 have been collected.
Data of patients treated in the hospital between January 2016 and January 2019 have been collected.
Detailed Description:
Coordinator investigator have put in place a protocol care for children with second degree burns since 2016.
It consists in detersion and cleaning of wound, application of ialuset cream and gauzepad (hyaluronic acid) during 21 days. After 21 days if patients are not healed, physician consider to perform grafting
It consists in detersion and cleaning of wound, application of ialuset cream and gauzepad (hyaluronic acid) during 21 days. After 21 days if patients are not healed, physician consider to perform grafting
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: